ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Ellipsis Health Named Accenture HealthTech Innovation Challenge Champion SimX named Top Innovator

Accenture (NYSE: ACN) names Ellipsis Health Innovation Champion and SimX Top Innovator in this year’s HealthTech Innovation Challenge, which supports finding innovative approaches and solutions to help create better healthcare access, experiences and ultimately outcomes for all people.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210929005334/en/

HealthTech Innovation Challenge 2021: Congratulations to the lead innovators! (Photo: Business Wire)

HealthTech Innovation Challenge 2021: Congratulations to the lead innovators! (Photo: Business Wire)

Ellipsis Health, based in San Francisco, CA, was named the Innovation Champion in this year’s Challenge. By using the words people say and how they say them, Ellipsis Health has pioneered an artificial intelligence-powered, speech-based vital sign to identify, quantify and manage depression, and anxiety symptoms at scale. Its integrated behavioral health solution aids time-strapped healthcare providers (frontline workers, PCPs, case managers, nurses, etc.) and payers to reliably identify and stratify patient populations – facilitating scalable behavioral health screening and longitudinal monitoring of symptoms and treatment efficacy.

“Thank you to the Accenture HealthTech Innovation Challenge and to the high-caliber of judges for recognizing Ellipsis Health’s unique role in pioneering a new clinical standard in mental health care using AI and the unique power of voice,” said Susan Solinsky, co-founder, CGO & COO, Ellipsis Health. “We are honored to have joined a cohort of companies who are transforming health care through technology and for the opportunity to amplify the importance of voice for measurement-based care in mental health.”

Additionally, the Challenge’s Top Innovator is SimX, located in San Francisco, CA. The company brings virtual and augmented reality to medical simulation training. With its completely immersive environments, SimX is used to train physicians, nurses, and other allied health professionals in a variety of medical scenarios. Furthermore, the platform allows medical teams to replace expensive mannequins with a low-cost, wireless VR headset, and an incredibly flexible virtual patient.

Dr. Ryan Ribeira, CEO, SimX said, “The challenge has been an exciting journey, and we’re delighted to be named the Top Innovator. At a time when healthcare innovation is front of mind for everyone, we’re honored to be recognized among a finalist group that is having a tremendous impact on the cost, quality, and equity of the medicine we deliver.”

The awards were presented after a round of pitches and judging on September 28 in a virtual event. The judging panel included executives from globally recognized health and venture capital companies, providing the eight finalists with exposure and access to industry-leading experience to help bring their ideas to market.

Brian Kalis, managing director of digital health and innovation services at Accenture, said, “we received a diverse group of innovative digital health solution submissions this year. These are companies reimagining healthcare in ways that will improve access, experience and outcomes for all people, and we look forward to working with them to continue to move the healthcare industry forward.”

The finalists were judged on criteria including their solution’s innovativeness, design quality, potential impact on patient outcomes, scalability, and effectiveness as a disruptive business model. The other six finalists were: Angle Health, Axle Health, Donisi Health, Ōmcare, Phyxable and Spora Health. Learn more about all the finalists at www.accenture.com/healthtechchallenge.

The Accenture HealthTech Innovation Challenge is an initiative sponsored by Accenture Health and Accenture Ventures, which is focused on accelerating the adoption of early-stage enterprise technology innovations. Accenture Health harnesses the power of technology and human ingenuity to help clients improve access, experience and outcomes in healthcare. With the help of our innovative, technology-enabled services, clients are delivering effective and personalized experiences that humanize healthcare for all. For more information, visit www.accenture.com/health.

About Accenture

Accenture is a global professional services company with leading capabilities in digital, cloud and security. Combining unmatched experience and specialized skills across more than 40 industries, we offer Strategy and Consulting, Interactive, Technology and Operations services — all powered by the world’s largest network of Advanced Technology and Intelligent Operations centers. Our 624,000 people deliver on the promise of technology and human ingenuity every day, serving clients in more than 120 countries. We embrace the power of change to create value and shared success for our clients, people, shareholders, partners and communities. Visit us at www.accenture.com.

Accenture Disclaimer

Accenture’s support of the selected companies will help them as they further develop their solutions and products. In supporting such initiatives, however, Accenture is in no way promoting or intending to market any one particular solution or product or otherwise offer or market a medical device or clinical solution. Each company uses its own operations to ensure compliance with applicable laws and regulations.

Copyright ©2021 Accenture. All rights reserved. Accenture and its logo are registered trademarks of Accenture.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.